- Israeli med-tech venture capital firm Peregrine Ventures raises $115M for its fourth fund focused on investing in early-stage medical technology startups. - To date, the VC firm has 10 exits totaling more than $2 billion in cumulative value and has over $200M in capital under management.Peregrine Ventures, a leading Israeli med-tech venture capital fund, today announced it has closed its fourth medtech-focused fund, Peregrine 4, raising $115 million. Their fourth medtech fund includes some of
Read More
Israeli Digital Health Startups | Healthcare Innovation | News, Analysis, Insights - HIT Consultant
Unlike Theranos: FDA Clears Sight Diagnostics’ Finger-Prick Blood Test for U.S. Market
- Sight Diagnostics, the company working to provide patients with lab-grade blood testing results in minutes, has received US FDA 510(k) clearance for its finger-prick blood test, OLO analyzer to be used in laboratories run by diagnostic providers and hospitals.
- Sight Diagnostics’ patented OLO analyzer digitizes blood into images to perform the most common blood test in minutes, from just two drops of blood
- The FDA clearance follows clinical trials at Boston Children’s Hospital,
Read More
MaxQ AI Integrates With Philips CT System for Hospitals & Radiology Departments
- MaxQ AI’s ACCIPIO® ICH and stroke software will be integrated on Philips CT systems and will be available to hospitals and radiology departments throughout the U.S. and E.U.MaxQ AI, an Israeli-based medical diagnostic AI company announced that the company’s Accipio intracranial hemorrhage (ICH) and stroke software will be integrated on Philips’ computed tomography (CT) systems. MaxQ AI will be demonstrating the company’s full suite of Accipio solutions during the upcoming Radiological Society
Read More
Syqe Medical, TerrAscend to Distribute Medical Cannabis Inhaler to Canadian Market
- Syqe Medical, Ltd. and TerrAscend Corp. announced an exclusive distribution agreement to bring Syqe’s flagship product, the SyqeTM Inhaler, to the Canadian market.
- TerrAscend will utilize their platform to both provide high-quality guidance to patients on use of the Syqe device and educate the medical community on the benefits of medical cannabis and the Syqe treatment.
- For the first time ever, the amount of THC in the bloodstream can be accurately controlled in a consistent,
Read More
Israeli Startup MDClone Lands $26M to Expand Healthcare Data Sandbox
MDClone, an Israeli-based provider of the world’s first healthcare data sandbox has raised $26 million in Series B funding led by aMoon with participation from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners. MDClone plans to utilize the funding to further develop its existing platform and build new products and novel approaches leveraging data across its global network, as well as accelerate sales and marketing efforts.Healthcare Data Sandbox: Explore and Discover
Read More
Geisinger Selects EarlySign to Apply AI Algorithms to Identify Patients At Risk of Lower GI Disorders
Geisinger Health System announced it is partnering with machine learning solution provider EarlySign to develop AI-based solutions to identify individuals at risk of a range of chronic and high-burden diseases. The multi-year agreement will begin by deploying EarlySign’s LGI Flag through Geisinger’s Steele Institute for Health Innovation – to identify patients at risk of lower gastrointestinal conditions – including colorectal cancer and precancerous adenomas. This partnership follows the
Read More
Syqe Medical Releases Pharmaceutical-Grade Medical Marijuana Inhaler
Syqe Selective-Dose Inhaler
Syqe Medical, an Israeli pharma-tech company, recently launched its newest administering device for cannabis in the form of a non-combustion inhaler.
The Syqe Inhaler™ is the company’s flagship product that utilizes innovative technology to administer proper doses of cannabis for medical marijuana patients in Israel. Syqe’s breakthrough drug delivery technology introduces complex respiration technique automation, electronic selective dosing, remote clinical
Read More
MaxQ AI Launches FDA Cleared, CE Approved Slice-Level Intracranial Hemorrhage Detection
MaxQ AI, an Israeli-based medical diagnostic AI company has launched the company’s new ACCIPIO Ax solution, which features SliceMap, an integrated view that guides clinicians rapidly to CT slices with suspected intracranial hemorrhage (ICH) without leaving their PACS viewer. Slice-Level Intracranial Hemorrhage DetectionACCIPIO Ax is FDA Cleared, CE Approved, and the second component of MaxQ AI’s ACCIPIO ICH Platform, the complete ICH solution for stroke and head trauma assessment. Radiology
Read More
Intermountain and MDClone Integrate to Transform Patient Data into Actionable Insights
Intermountain Healthcare, today announced it is teaming up with Israeli healthcare IT company MDClone to increase caregivers’ ability to transform patient data into information they can use to help people lead the healthiest lives possible. As part of the collaboration, MDClone will share a new approach to healthcare data access, analytics, and research with Intermountain. The new partnership will further transform its existing rich data sources into more meaningful information that will enable
Read More
Israeli Telehealth Startup TytoCare Extends Series C, Bringing Total Funds to $33.5M
TytoCare, an Israeli-based telehealth company, today announced it has extended its Series C funding to add key strategic investors, bringing the total funds raised to $33.5M. This is an extension of the oversubscribed 2018 round led by Ping An Global Voyager Fund with new investors Shenzhen Capital Group of China, Japan’s Itochu, and Sanford Health of the US.Founded in 2012, TytoCare has three telehealth products: TytoHome™ for consumers, TytoPro™ for professionals, and TytoClinic™ for remote
Read More
